Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucose-6-phosphate (G6P) is a central carbohydrate metabolite that occupies a critical junction in cellular metabolism, connecting glycolysis, the pentose phosphate pathway (PPP), gluconeogenesis, and glycogen synthesis. It is primarily produced by the phosphorylation of glucose by hexokinase or glucokinase, a reaction that effectively traps the sugar within the cell due to the negative charge of the phosphate group. In the pentose phosphate pathway, G6P serves as the substrate for glucose-6-phosphate dehydrogenase (G6PD), generating NADPH for antioxidant defense and ribose-5-phosphate for nucleotide biosynthesis. While G6P itself is a metabolite and not a traditional therapeutic target like an enzyme or receptor, the proteins that regulate its flux—such as G6PD and glucose-6-phosphatase—are major targets in oncology and metabolic disease research. Dysregulation of G6P levels is a hallmark of the Warburg effect in cancer cells and is central to the pathology of various glycogen storage diseases.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucose-6-phosphate (G6P).